Canadian Researchers Uncover Key Weakness in Glioblastoma Brain Cancer

Researchers in Canada have identified a communication network between specific brain cells and glioblastoma tumors that may be driving the growth of the cancer. This discovery reveals a vulnerability in the most aggressive and currently incurable type of brain cancer, suggesting that disrupting these signals could significantly slow tumor progression.

The study, published in the journal Neuron on January 21, 2026, was conducted by scientists at McMaster University and The Hospital for Sick Children (SickKids). The team found that certain brain cells, which were previously believed to only support normal nerve function, actually assist glioblastoma by sending signals that strengthen the cancer cells.

Mechanism of Tumor Growth

Glioblastoma is characterized by a poor prognosis, with survival often measured in months. The research indicates that the tumor does not exist as a simple mass of cancer cells, but rather as a complex ecosystem.

Glioblastoma isn’t just a mass of cancer cells, it’s an ecosystem

Sheila Singh, co-senior author of the study and professor of surgery at McMaster University

By decoding the way these brain cells communicate with the tumor, the researchers were able to block this signaling process in laboratory models. This intervention resulted in a significant drop in tumor growth.

Potential for Drug Repurposing

The findings highlight a potential treatment opportunity through the repurposing of an existing medication. The researchers discovered that a drug currently used to treat HIV might be able to interfere with the communication between the brain cells and the glioblastoma tumors.

Because patients with glioblastoma currently have very limited treatment choices, the possibility of using an approved HIV drug offers a potential new path toward treatment.

Research Background and Team

The study was led by scientists at McMaster University and SickKids. The co-first authors of the research are Nick Mikolajewicz, who was a postdoctoral fellow in the Moffat Lab at SickKids at the time of the study, and Kui Zhai, a research associate in the Singh Lab at McMaster.

This work builds upon a 2024 study published in Nature Medicine by Singh and Moffat. That previous research discovered that glioblastoma could hijack migration paths used by cells during brain development to facilitate cancer cell invasion.

Together, these two discoveries emphasize a research direction focused on dismantling the complex communication networks that glioblastoma relies on to grow and spread.

Sheila Singh, who also serves as the director of the Centre for Discovery in Cancer Research at McMaster, noted that by identifying these communication patterns, the team found a vulnerability that could be targeted with a drug already on the market.